More Potential
Boehringer Ingelheim steps up its commitment to sustainable development, building on its historical success in addressing unmet health needs and increasing its ambitions to tackle global health and societal challenges.
Search
More Green
More Green
More Health: For People & Animals
More Health: For People & Animals
Product Defect Correction
Reporting of a Potential Defect in the Dose Counter: Spiriva Respimat® Solution for Inhalation 2.5ug
Chronic Kidney Disease
Chronic Kidney Disease
Drug Discovery at Boehringer Ingelheim
Find out more about the drug discovery process at Boehringer Ingelheim
Depression
Depression
Horses Health
Horses
Scleroderma (SSc)
Systemic sclerosis is a complex rare disease with a variable course. It presents with a range of symptoms involving several different organs
Partnering
Partnering
Taking Animal Health Forward: Industry experts share their view at NZVA & NZVNA Conference
24 June, Christchurch: The animal health sector needs to change to keep up with the times, according to the discussion at a breakfast event hosted by Boehringer Ingelheim at the NZVA and NZVNA Conference in Christchurch
Accelerating gender equality at Boehringer Ingelheim
Accelerating gender equality at Boehringer Ingelheim
Vision & Values
Vision & Values
Generalised Pustular Psoriasis (GPP)
GPP
Accessibility Statement
Accessability Statement
Heart Failure
Heart Failure
About Us
About us
Ruminants Health
Ruminants
Putting a green spotlight on health
Boehringer Ingelheim’s new-generation reusable and propellant-free inhalers
Animal Health: Our Responsibility
Our Responsibility
Science Stories
Science Stories
Angels Initiative
Angels Initiative
Lung Diseases
Lung Diseases
Corporate Profile
Corporate Profile
The Angels Initiative Surpasses 1,000 Registrations for Acute Stroke Training
Global program equips HCPs for optimal acute stroke treatment